medical-technology

His customers—makers of aerospace, laser, medical-technology and oil-drilling-equipment— "seem to be a little more relaxed and stable," he said.

Durable-Goods Orders Drop Justin Lahart 2011

Mori and Yamada's biggest miscalculations came when they tried to navigate the complexities of a deal to buy an overseas medical-technology company.

At Olympus, Stumbles in Scandal Juro Osawa 2011

Mori and Yamada wrote off those losses using $687 million in fees attached to Olympus's acquisition of U.K. medical-technology firm Gyrus Group PLC as cover.

Panel Calls Olympus 'Rotten' at Core Daisuke Wakabayashi 2011

Getting the right people is paramount to what we're trying to do now,'' explains Thomas Ruddy , vice president of talent management at the medical-technology concern.

Employers Put Executive Job Candidates to the Test Joann S. Lublin 2011

The deals being examined by the committee include the $1.9 billion purchase of U.K. medical-technology firm Gyrus Group Ltd. in 2008, for which a little-known financial adviser based in the Cayman Islands received a total payout of $687 million.

Olympus Delays Earnings Release Kana Inagaki 2011

Last year, a medical-technology firm called Numira Biosciences, founded in 2005 in Irvine, California, packed its bags and moved to Salt Lake City.

Cali to Business: Get Out! Steven Malanga 2011

Some observers fear, however, that high efficiency might stifle medical-technology investments.

Wonk Room » Thomas Scully: ‘Medicare Makes Decisions On Coverage All The Time, I Made Decisions On Coverage All The Time’ 2009

NEW YORK — Kinetic Concepts Inc. 's shares slumped Tuesday after a judge rendered invalid two key patents the medical-technology company has used to defend its wound-therapy franchise.

Judge Rules Kinetic Concepts' Patents Invalid Jennifer Cummings 2010

The panel also will look at the booking of advisory fees relating to the acquisition of U.K. medical-technology company Gyrus Group PLC as goodwill.

Panel Begins Look at Olympus Auditor Kana Inagaki 2011

In one of the deals for which Olympus is under scrutiny, the company paid adviser Axes America and an affiliate $687 million for work on the $1.9 billion purchase of U.K. medical-technology firm Gyrus Group Ltd. in 2008.

Nobel Economist Served on Olympus Board Phred Dvorak 2011